Scriver’s OMMBID: A Comprehensive Online Resource for Genetic Diseases

Scriver’s OMMBID from McGraw-Hill Medical is a vital online resource that delivers extensive coverage of the genes and genetic mechanisms underlying human disease states. Based on the world’s most respected book on the subject, Metabolic and Molecular Bases of Inherited Disease, first published in 1960, Scriver’s OMMBID is an indispensable digital reference tool that provides geneticists, researchers, students, clinicians, and fellows involved with the causation and treatment of inherited diseases — with cutting-edge information spanning the entire field of genetics.

More than just a literature synopsis, OMMBID provides the latest knowledge on the metabolic and molecular underpinnings of a growing list of inherited diseases, as well as updates on pathophysiology and treatment. This digital resource is a must-have for anyone involved in the study or treatment of genetic disorders, offering comprehensive insights into the genetic mechanisms that underpin human diseases.

Key Features of Scriver’s OMMBID

• Comprehensive coverage of genetic diseases: OMMBID covers a wide range of inherited diseases, providing detailed information on their genetic and molecular bases.
• Regular updates: The resource is regularly updated to reflect the latest research findings and advancements in the field of genetics.
• Accessible format: OMMBID is designed to be user-friendly, making it easy for users to navigate and find the information they need.
• Authority and credibility: As a digital version of the renowned Metabolic and Molecular Bases of Inherited Disease, OMMBID is a trusted source of information for geneticists and researchers.

Subscription Details

Scriver’s OMMBID is available for subscription at a price of $20 per year. The subscription comes with a one-year guarantee, ensuring that users have access to the latest information and updates in the field of genetics. Account login details will be delivered within 24-72 hours of purchase, depending on account availability.